SCARB1 and Ewing sarcoma: In conclusion, we have identified SR-B1 as a potential biomarker with diagnosis values in liposarcoma, which was significantly increased in liposarcoma, compared with rhabdomyosarcoma, leiomyosarcoma and Ewing's sarcoma.